LATE-BREAKING ABSTRACT: Reslizumab in patients with late-onset asthma with elevated blood eosinophils
Guy Brusselle, Matthew Germinaro, Sherrine Eid, James Zangrilli
European Respiratory Journal 2015 46: OA287; DOI: 10.1183/13993003.congress-2015.OA287
Guy Brusselle
1Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium
Matthew Germinaro
2Global Respiratory Research and Development, Teva Pharmaceuticals, Frazer, United States
Sherrine Eid
3Biostatistics, Teva Pharmaceuticals, Frazer, United States
James Zangrilli
4Global Respiratory Research and Development, Global Branded Products, Teva Pharmaceuticals, Frazer, United States
Vol 46 Issue suppl 59
Table of Contents
LATE-BREAKING ABSTRACT: Reslizumab in patients with late-onset asthma with elevated blood eosinophils
Guy Brusselle, Matthew Germinaro, Sherrine Eid, James Zangrilli
European Respiratory Journal Sep 2015, 46 (suppl 59) OA287; DOI: 10.1183/13993003.congress-2015.OA287